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A multifun~on~ receptor for ~-fo~yl~ptides exists on the membranes of neutroph~s. This receptor 
has now been isolated from ~eutrop~ls derived from HL-60 promyeloc~i~ leukemia cells. After 
solubi~tion by Nonidet-P4O and p~ifi~tion by affinity ~hromato~aphy and HPLC the isolated 
receptor was reconstituted into egg phosphatidylcholine v sicies by SM-2 Bio-Bead removal of the 
NonideGP40. Analysis of the affinity and selectivity of the receptor was done by direct binding of two 
high-affinity ligands, formyl-Met-Leu-[“HIPhe-OH and formyl-Nle-Leu-Phe-(3H]Tyr-OH. The data 
suggest that the receptor can be isolated and reconstituted without apparent alteration of its binding 
affhrity and selectivity, and that there appear to be no co-factors or subunits upon which these binding 
characteristics are dependent. 
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1. INTRODUCTION 
A multifunctional receptor for low-M, 
chemotactic oligopeptides, of which N- 
formylmethionylleucylphenylalanine-OH (FMLP) 
is the prototype, exists on the membrane of mam- 
malian phagocytes [l-3], These peptides timulate 
chemotaxis, lysosomal enzyme secretion and a 
variety of other cellular responses by interaction 
with this specific membrane receptor, often re- 
ferred to as simply the chemotactic peptide recep- 
tor. This -receptor has been solub~ed from 
human [4,5] and rabbit 161 neutrophils and subse- 
quently purified from human neutrophils by af- 
finity chromatography [S]. The major protein 
isolated had an M, of -68 000 and retained its high 
affinity for FMLP. 
paper we describe the solubilization and isolation 
of the chemotactic receptor from HL-60 derived 
neutrophils, and the subsequent reconstitution of 
the receptor into egg phosphatidylcholine (PC) 
vesicles. 
2. EXPERIMENTAL 
Neutrophils derived from HL-60 promyelocytic 
leukemia cells have also been shown to express the 
FMLP receptor [7,8]. The potential for growth of 
large quantities of these cells prompted us to use 
this source for isolation of enough receptor to at- 
tempt heir reconstitution i to lipid vesicles. In this 
HL-60 promyel~~ic leukemia cells were roller 
cultured in 850-cm2 roller bottles (1 rpm) in media 
consisting of RPM1 1640, 10% fetal calf serum, 
5% glut~ine, and 50000 units/l of penicillin- 
streptomycin. Rattles were seeded at 4 x 10’ 
cells/ml and stimulated with 1.25% dimethyl 
sulfoxide and 10T5 M dexamethasone. After 7 days 
the cells were at a density of approx. 3 x 10’ 
cells/ml, with >95% differentiated into band cells 
and metamylocytes. Approx. 2 x 10’ cells were 
collected and suspended in 0.1 M NaCl, 10 mM 
Hepes and 2.5 mM MgClz (pH 7.2) and disrupted 
by Nz cavitation [9]. The crude membrane frac- 
tions consisting of both the 4 x 10s gemin and 9 x 
106 g-min pellets were pooled, resuspended in 
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Fig.1. Scatchard plots for FML[%]P binding tu: (A) intact HLC-60 neu~oph~~s~ (B) reconstituted affinity column 
eluate, and (c) reconstituted 66 kDa peak. Abscissa: (A) fmol specific bound per 106 ceils, (B and C) fmot specific 
bound per tube. 
0.1 M NaCl, IO mM Hepes fpH 7.2) to about 
1 mg/ml and solubilized with 0.6% Nonidet-P40. 
The solubilized solution was passed twice over a 
2 ml AH Sepharose 4B affinity column coupled to 
FMLP (10-l 5 pmol/g dried resin as determined by 
amino acid analysis), washed with 20 ml of 
solubilization buffer, and eluted with another 6 ml 
of buffer containing 20 mg FMLP (dissolved in 
200 pl dimethyl s&f&tide). The receptor-rich 
eluate was s~multan~~ly dialyzed and concen- 
trated to about 0.5 ml by vacuum ultrafiltration 
across a dialysis sac (MI cut-off 14000) in 0.1 M 
NaCl, 10 mM Hepes and 0.03 ml Nonidet-P40/1 
(pH 7.2). The concentrate was then chromato- 
Table 1 
Affinity of FMLP and FNLPT for in situ and 
reconstituted receptors 
Preparation Kd @Ml 
FMLP FNLPT 
fntact cells 28 s 
Reconstituted affinity 
column eluate 27 9 
Reconstituted 66 kDa 
peak from HPLC 27 10 
Formylmethiony~eu~lph~y~~~~~e (FMLP) and 
formylnorleucylleucy~phenylalanyityrosine (FNLPT) 
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graphed in the same buffer by HPLC on a cali- 
brated TSK 4000 sizing column, and the 66 kDa 
peak collected and reconcentrated by vacuum 
ultrafiltration. 
Egg PC (2 mg/ml) was dried under Nz, 
resuspended in 0.1 M NaCl, 10 mM Hepes and 
1 mM CaClz (pH 7.2) and solubilized to absolute 
clarity with Nonidet-P40. Approx. 0.7 yg/ml of 
prutein from the concentrated 66 kDa fraction, or 
1.6 pg/ml of protein from the concentrated affini- 
ty column eluate were added to the solubilized PC 
solution, followed by 0.5 g/ml SM-2 Bio-Beads. 
The Bio-Beads were prepared as in [lo] and the 
vesicles prepared according to [l l]. 
Direct binding to the resulting receptor contain- 
ing PC vesicles was evaluated by a standard filtra- 
tion assay [l2] using two high-affinity ligands, 
FMLE3H]P and formyl-Nle-Leu-Phe-[3H]Tyr-OH 
[FNLPC3H]T]. Data were analyzed as in [13]. 
Protein was estimated from the chromatograms 
using bovine albumin as the standard. The detector 
was set at 246 run which shows sufficient sensitivi- 
ty for protein while minimizing the absorbance of 
Nonidet-P40, 
3. RESULTS 
Our early solubilization studies showed that 
Nonidet-P40, CHAPS, and digitonin, but not #- 
octylglucopyranoside, could be used to solubilize 
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the chemotactic receptor from HL-60 neutrophils. 
Equilibrium dialysis binding analysis of the 
preparations showed unaltered affinities for 
FMLP, but due to the difficulty in working with 
digitonin, and the receptor’s apparent instability in 
CHAPS, Nonidet-P40 was chosen for further 
studies. The solubilized receptor was stable for 
over a week when stored at 4”C, but was inac- 
tivated when freeze-thawed. The stability of the 
reconstituted receptor followed the same pattern. 
Fractionation of the concentrated affinity col- 
umn eluate by HPLC on a TSK 4000 sizing column 
showed a large predominating 66 kDa peak and 
two smaller peaks of approx. 130 kDa and 
250 kDa. When the 66 kDa peak was collected, 
reconcentrated and rechromatographed it produc- 
ed a single symmetrical peak. Typically, l-2 pg of 
protein were obtained from 2 x lo9 cells. 
There was no significant change in the affinity 
and selectivity of the reconstituted receptor as 
determined by direct binding of the two high- 
affinity ligands (table 1). Scatchard analysis of the 
binding data indicates a single population of sites 
for FMLP (fig.1) and FNLPT (not shown). To 
determine if the receptor’s binding characteristics 
were dependent upon or altered by a co-factor pre- 
sent in the intact cell or a subunit which coeluted 
from the affinity column, the Kd values were deter- 
mined for the reconstituted affinity column eluate 
as well as for the isolated 66 kDa peak. There were 
no significant differences between the two (table 
1). 
4. DISCUSSION 
The Nonidet-P40 solubilized chemotactic recep- 
tor from HL-60 derived neutrophils has been 
isolated and successfully reconstituted into PC 
vesicles with no apparent loss of binding affinity or 
selectivity. The receptor from these cells isolates as 
a 66 kDa protein, which is in agreement with that 
previously determined for the receptor isolated 
from human neutrophils [5]. The receptor appears 
to be quite stable in both its solubilized and 
reconstituted forms, thus facilitating its isolation 
and handling. 
Although it cannot be stated with certainty, the 
retention of affinity and selectivity throughout the 
isolation procedures suggests that there are no 
essential co-factors upon which binding of FMLP 
is dependent. Furthermore, the use of the HL-60 
cell line is a distinct advantage in that development 
and optimization of isolation and reconstitution 
procedures are greatly facilitated by an abundant 
starting material. Retention of binding affinity 
through both the affinity chromatography and 
HPLC purification steps indicates that the recep- 
tor is not absolutely dependent upon native lipid 
for its successful reconstitution or ligand binding. 
Finally, it must be realized that the functionality 
of this isolated receptor cannot be inferred from 
the retention of binding characteristics. The 
measurement of functionality of reconstituted 
receptors has been achieved only with the nicotinic 
receptor [14] and recently in a coupled assay with 
solubilized (but not isolated) fl-adrenergic receptor 
[ 151. The measurement of a functional response of 
the reconstituted FMLP receptor remains an im- 
portant goal 
In summary, the FMLP receptor of HL-60 
derived neutrophils has been isolated and 
reconstituted. This, we believe, offers a unique op- 
portunity to study this important receptor, as well 
as providing a well defined system to study 
ligand-receptor interactions in general. 
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